By isolating and focusing on stimulating only the M cells on the retina, they created a new color signal that the human eye ...

Tyrosine Kinase Inhibitors to Prolong Efficacy of Anti-VEGF Therapies ...

Tyrosine Kinase Inhibitors to Prolong Efficacy of Anti-VEGF Therapies ...

Tyrosine Kinase Inhibitors to Prolong Efficacy of Anti-VEGF Therapies ...

Tyrosine Kinase Inhibitors to Prolong Efficacy of Anti-VEGF Therapies ...

Beth Marsh is stepping into the role of Neurotech Pharmaceuticals’ chief commercial officer (CCO) beginning April 28. Marsh will lead the organization, particularly as it prepares for the US launch of ...

Abby Markward, MBA, executive director of the ASCRS Foundation and the ASOA, provides a sneak peek of the posterior segment-focused event. From April 25-28, the American Society of Cataract and ...

Tyrosine Kinase Inhibitors to Prolong Efficacy of Anti-VEGF Therapies ...

Tyrosine Kinase Inhibitors to Prolong Efficacy of Anti-VEGF Therapies ...

Researchers from the Czech Republic found that an AI system showed higher sensitivity and specificity for screening diabetic retinopathy compared to telemedicine evaluations.